P
CELC icon

Pfizer’s Celcuity CELC Stock Holding History

Pfizer’s Portfolio CELC Stock Details CELC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.3M Sell
295,652
-53,754
-15% -$5.86M 13.13% 4
2025
Q4 		$34.8M Hold
349,406
– – 14.74% 3
2025
Q3 		$17.3M Hold
349,406
– – 3.95% 6
2025
Q2 		$4.66M Hold
349,406
– – 0.81% 12
2025
Q1 		$3.53M Hold
349,406
– – 0.71% 12
2024
Q4 		$4.57M Buy
+349,406
New +$4.93M 0.18% 14

Other funds holding CELC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pfizer's CELC Position: Q1 2026 in Review

Pfizer reduced its Celcuity (CELC) stake by 15% in Q1 2026, selling an estimated $5.86M and leaving 295,652 shares worth $31.3M. The position accounts for 13.13% of the portfolio, ranked #4.

Pfizer first reported a position in CELC in Q4 2024 and has held it in 6 quarters since. The position peaked at $34.8M in Q4 2025. 275 funds tracked by Wall St. Rank hold CELC as of Q1 2026.

  • Pfizer held 295,652 shares of Celcuity worth $31.3M as of Q1 2026.
  • Pfizer sold 53,754 Celcuity shares in Q1 2026, an estimated $5.86M.
  • Celcuity made up 13.13% of Pfizer's portfolio in Q1 2026, its #4 holding.
  • Pfizer first reported a position in Celcuity in Q4 2024 and has held it in 6 quarters since.
  • Pfizer's Celcuity position peaked at $34.8M in Q4 2025.
  • 275 funds tracked by Wall St. Rank held Celcuity as of Q1 2026.

Based on Pfizer's 13F filing for Q1 2026, filed 12 May 2026.